The European Medicines Agency wants marketing authorization application filing dates to be jointly agreed with companies based on dossier maturity, but industry is seeking safeguards for situations in which the dialog breaks down.
The European Medicines Agency wants marketing authorization application filing dates to be jointly agreed with companies based on dossier maturity, but industry is seeking safeguards for situations in which the dialog breaks down.